Bosch Developing COVID-19-(SARS-CoV-2) Rapid Testing Kit for the Vivalytic Platform

▴ COVID-19-(SARS-CoV-2) Rapid Testing Kit
The Vivalytic platform is so easy to use that it can be handled in any clinic or medical practice without the need for laboratory personnel: The sample is taken from the patient's nose or throat using a swab and placed in the cartridge without any complex preparation.

Bosch Healthcare Solutions is currently working on the development of a COVID-19 rapid testing kit for the Vivalytic platform and will launch this in April 2020.

The Vivalytic VRI test (Viral Respiratory Tract Infections) checks the patient's sample for the SARS CoV-2 virus, which can lead to COVID-19, as well as nine other possible viral respiratory diseases. To prevent the continued rapid spread of COVID-19, it is necessary to identify infectious patients with and without symptoms. With the Vivalytic VRI test, physicians can quickly and efficiently distinguish between different infections with very similar symptoms, like influenza, and immediately begin the appropriate treatment.

The test delivers a reliable result based on WHO guidelines in less than 2.5 hours at the point of care, i.e. in close proximity to where the patient's sample was collected. This means a time-consuming logistics chain, in which the samples have to be transported, is no longer necessary.

"Together with our partner Randox, we have adapted the manual COVID-19 test, which has existed just a few weeks, to the new, fully automated Vivalytic platform from Bosch," said Marc Meier, Managing Director of Bosch Healthcare Solutions GmbH. "Thanks to the extensive expertise of both companies, we have succeeded in developing an innovative test in a very short time, which can contribute to curbing the global spread of the coronavirus."

The Vivalytic platform is so easy to use that it can be handled in any clinic or medical practice without the need for laboratory personnel: The sample is taken from the patient's nose or throat using a swab and placed in the cartridge without any complex preparation. The Vivalytic analyser then fully automatically processes the cartridge, which already contains all the reagents required for the test. Since the system in each cartridge is isolated, the risk of infection during handling is minimized.

Vivalytic is a universal platform for molecular diagnostics that can be used to perform various fully automatic laboratory tests in a short time. The open design of the platform makes it compatible with manual tests from various suppliers. The range of available tests is expected to grow steadily, enabling physicians to initiate successful therapies based on rapid diagnosis.

Tags : #Bosch #Vivalyticplatform #Randox #Covid19rapidtestingkit

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-

Trending Now

Male pattern baldness or Alopecia : What you should know September 18, 2020
China Biopharma plant leak infects thousands with bacterial diseaseSeptember 18, 2020
Alarming rates of transmission of virus in EuropeSeptember 18, 2020
WHO urges safety for health workers September 18, 2020
Moderna to seek COVID vaccine's limited emergency useSeptember 18, 2020
Global Coronavirus cases surpass 30 MillionSeptember 18, 2020
Moderna, Pfizer share COVID-19 vaccine trial blueprints September 18, 2020
UN asks Billionaires for help as 270 Million people face starvationSeptember 18, 2020
UK's COVID-19 test which gives faster results accurateSeptember 18, 2020
AstraZeneca resumes COVID-19 vaccine trials in South AfricaSeptember 17, 2020
Saudi Health Ministry warns against video claiming COVID-19 cureSeptember 17, 2020
Vaccine nationalism puts lives at risk says European Union chiefSeptember 17, 2020
US plans to distribute COVID vaccine immediately after authorizationSeptember 17, 2020
Trump counters CDC chief on vaccine timelineSeptember 17, 2020
A report states half of the vaccines are booked by rich nationsSeptember 17, 2020
Donald Trump on White House staff member testing positiveSeptember 17, 2020
Asian Airlines join trend of scenic flights to nowhere amid pandemicSeptember 17, 2020
Brazil authorizes additional 5,000 volunteers for AstraZeneca COVID-19 vaccineSeptember 17, 2020
China, UAE see positive results in Phase 3 COVID-19 vaccine trialsSeptember 16, 2020
Russia to sell Sputnik-V Vaccine to Dr Reddy's Laboratories September 16, 2020